ArticleJournal of nanobiotechnology2024

Combined SERS-Raman screening of HER2-overexpressing or silenced breast cancer cell lines.

Sara Spaziani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.